PNC Financial Services Group’s Precision BioSciences DTIL Stock Holding History

PNC Financial Services Group’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-13	Closed	-$2K	–	4563
2021 Q4	$2K	Hold	13	–	–	﹤0.01%	4148
2021 Q3	$4K	Hold	13	–	–	﹤0.01%	3984
2021 Q2	$6K	Sell	13 -14	-52%	-$4.21K	﹤0.01%	3825
2021 Q1	$8K	Sell	27 -1	-4%	-$350	﹤0.01%	3702
2020 Q4	$8K	Sell	28 -28	-50%	-$6.86K	﹤0.01%	3620
2020 Q3	$10K	Buy	56 +55	+5,500%	+$10.9K	﹤0.01%	3493
2020 Q2	$0	Buy	+1	New	+$219	﹤0.01%	3939
2020 Q1	–	Sell	-1	Closed	–	–	3924
2019 Q4	$0	Buy	+1	New	+$314	﹤0.01%	4010

Other funds holding DTIL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

OMC

OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

PNC Financial Services Group's DTIL Position: Q1 2022 in Review

PNC Financial Services Group sold out of Precision BioSciences (DTIL) in Q1 2022, closing a stake of 13 shares — an estimated $2K sold.

PNC Financial Services Group first reported a position in DTIL in Q4 2019 and held it in 8 quarters. The position peaked at $10K in Q3 2020. 152 funds tracked by Wall St. Rank hold DTIL as of Q1 2022.

PNC Financial Services Group reported no remaining Precision BioSciences position as of Q1 2022 after selling out during the quarter.
PNC Financial Services Group sold 13 Precision BioSciences shares in Q1 2022, an estimated $2K.
PNC Financial Services Group first reported a position in Precision BioSciences in Q4 2019 and held it in 8 quarters.
PNC Financial Services Group's Precision BioSciences position peaked at $10K in Q3 2020.
152 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2022.

Based on PNC Financial Services Group's 13F filing for Q1 2022, filed 12 May 2022.